Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy

por Damuzzo, V, Russi, A, Chiumente, M, Masini, C, Rebesco, B, Gregis, F, Nozza, S, Pigozzo, J, Chiarion-Sileni, V, Palozzo, AC
Publicado 2018

Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone

por Salvi, S, Casadio, V, Conteduca, V, Burgio, S L, Menna, C, Bianchi, E, Rossi, L, Carretta, E, Masini, C, Amadori, D, Calistri, D, Attard, G, De Giorgi, U
Publicado 2015

On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2

por Caffo, O., Zagonel, V., Baldessari, C., Berruti, A., Bortolus, R., Buti, S., Ceresoli, G.L., Donini, M., Ermacora, P., Fornarini, G., Fratino, L., Masini, C., Massari, F., Mosca, A., Mucciarini, C., Procopio, G., Tucci, M., Verri, E., Zucali, P., Buttigliero, C.
Publicado 2020

Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort

por Fornarini, G., Rebuzzi, S.E., Banna, G.L., Calabrò, F., Scandurra, G., De Giorgi, U., Masini, C., Baldessari, C., Naglieri, E., Caserta, C., Manacorda, S., Maruzzo, M., Milella, M., Buttigliero, C., Tambaro, R., Ermacora, P., Morelli, F., Nolè, F., Astolfi, C., Sternberg, C.N.
Publicado 2021